AI-powered lesion delineation in prostate cancer PET/CT imaging

FHS
June 29, 2024
3:23 am

A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning-assisted lesion segmentation in PET/CT imaging: A feasibility study for salvage radiation therapy in prostate cancer.”

ImmunityBio inks $320m deal to advance bladder cancer drug and boost pipeline – Pharmaceutical Technology

Share this article The latest investment brings ImmunityBio’s total financing from 2023 to $850m. Credits: jack8/Shutterstock.com ImmunityBio has started the year off strong by announcing

January 2, 2024

Study: Many approved cancer drugs lack proof of added benefit

Many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved through expedited (“fast

February 29, 2024

Study reveals BCG vaccine’s unexpected role in fighting influenza

As Canada’s flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory

February 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.